Prucalopride 13CD3
| Product Name | Prucalopride 13CD3 |
|---|---|
| Alternate Names | Prucalopride Stable Isotopes, Stable Isotopes of Prucalopride |
| CAT No. | CS-O-03354 |
| CAS No. | 179474-81-8 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 371.88 g/mol |
| Mol. For. | C₁₇¹³CH₂₃D₃ClN₃O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Prucalopride |
| Purity | 95% |
| Smileys | O=C(C1=CC(Cl)=C(N)C2=C1OCC2)NC3CCN(CCCO[13C]([2H])([2H])[2H])CC3 |
| Canonical Smiles | COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl |
| InchIKey | ZPMNHBXQOOVQJL-UHFFFAOYSA-N |
| Inchl | InChI=1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23) |
| IUPAC | 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Prucalopride 13CD3 is a medication used to treat chronic constipation in adults. It is a selective serotonin 5-HT4 receptor agonist that works by enhancing the motility of the gastrointestinal tract and promoting the passage of stool. Prucalopride 13CD3 is a deuterated version of the original prucalopride molecule, which means that some of the hydrogen atoms in the molecule have been replaced with deuterium atoms. This modification improves the pharmacokinetic properties of the drug, making it more effective and longer-lasting.
The recommended dose of Prucalopride 13CD3 is 2 milligrams per day, taken orally with or without food. It is important to follow the prescribed dosage and not to exceed it, as this can lead to adverse effects such as diarrhea, abdominal pain, and nausea. Prucalopride 13CD3 should not be used in patients with severe renal impairment or hepatic impairment, or in those who have a history of bowel obstruction, perforation, or severe inflammatory bowel disease.
In terms of chemical information, Prucalopride 13CD3 has a molecular formula of C18H16D3N3O2 and a molecular weight of 305.41 g/mol. Its chemical structure consists of a pyrimidine ring, an indole ring, and a piperidine ring, connected by various functional groups. Prucalopride 13CD3 is a stable compound that is soluble in water and organic solvents, and it can be synthesized using various deuterated reagents and catalysts. Overall, Prucalopride 13CD3 is a valuable medication for the treatment of chronic constipation, and its deuterated form provides improved therapeutic benefits.
Get an Instant Quote
Related Compounds
Prucalopride Succinate 13CD3 | Prucalopride-d5 |